These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 32825179)

  • 1. Diagnostic and Prognostic Indications of Nasopharyngeal Carcinoma.
    E A R ENS; Irekeola AA; Yean Yean C
    Diagnostics (Basel); 2020 Aug; 10(9):. PubMed ID: 32825179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-18a promotes malignant progression by impairing microRNA biogenesis in nasopharyngeal carcinoma.
    Luo Z; Dai Y; Zhang L; Jiang C; Li Z; Yang J; McCarthy JB; She X; Zhang W; Ma J; Xiong W; Wu M; Lu J; Li X; Li X; Xiang J; Li G
    Carcinogenesis; 2013 Feb; 34(2):415-25. PubMed ID: 23097559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of nasopharyngeal carcinoma in Morocco (North Africa) using a multiplex methylation-specific PCR biomarker assay.
    Nawaz I; Moumad K; Martorelli D; Ennaji MM; Zhou X; Zhang Z; Dolcetti R; Khyatti M; Ernberg I; Hu LF
    Clin Epigenetics; 2015; 7(1):89. PubMed ID: 26300994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus mir-bart1-5p detection via nasopharyngeal brush sampling is effective for diagnosing nasopharyngeal carcinoma.
    Zheng XH; Lu LX; Cui C; Chen MY; Li XZ; Jia WH
    Oncotarget; 2016 Jan; 7(4):4972-80. PubMed ID: 26701721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a non-invasive method, multiplex methylation specific PCR (MMSP), for early diagnosis of nasopharyngeal carcinoma.
    Zhang Z; Sun D; Hutajulu SH; Nawaz I; Nguyen Van D; Huang G; Haryana SM; Middeldorp JM; Ernberg I; Hu LF
    PLoS One; 2012; 7(11):e45908. PubMed ID: 23144779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repression of DERL3 via DNA methylation by Epstein-Barr virus latent membrane protein 1 in nasopharyngeal carcinoma.
    Kondo S; Okabe A; Nakagawa T; Matsusaka K; Fukuyo M; Rahmutulla B; Dochi H; Mizokami H; Kitagawa Y; Kurokawa T; Mima M; Endo K; Sugimoto H; Wakisaka N; Misawa K; Yoshizaki T; Kaneda A
    Biochim Biophys Acta Mol Basis Dis; 2023 Feb; 1869(2):166598. PubMed ID: 36372158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr Virus_Encoded LMP1 upregulates microRNA-21 to promote the resistance of nasopharyngeal carcinoma cells to cisplatin-induced Apoptosis by suppressing PDCD4 and Fas-L.
    Yang GD; Huang TJ; Peng LX; Yang CF; Liu RY; Huang HB; Chu QQ; Yang HJ; Huang JL; Zhu ZY; Qian CN; Huang BJ
    PLoS One; 2013; 8(10):e78355. PubMed ID: 24194922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exosomal cyclophilin A as a novel noninvasive biomarker for Epstein-Barr virus associated nasopharyngeal carcinoma.
    Liu L; Zuo L; Yang J; Xin S; Zhang J; Zhou J; Li G; Tang J; Lu J
    Cancer Med; 2019 Jun; 8(6):3142-3151. PubMed ID: 31063269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating Epstein-Barr virus microRNAs miR-BART7 and miR-BART13 as biomarkers for nasopharyngeal carcinoma diagnosis and treatment.
    Zhang G; Zong J; Lin S; Verhoeven RJ; Tong S; Chen Y; Ji M; Cheng W; Tsao SW; Lung M; Pan J; Chen H
    Int J Cancer; 2015 Mar; 136(5):E301-12. PubMed ID: 25213622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of Epstein-Barr virus-encoded latent membrane protein (LMP-1), p16 and p53 proteins in nonendemic nasopharyngeal carcinoma (NPC): a clinicopathological study.
    Rosales-Pérez S; Cano-Valdez AM; Flores-Balcázar CH; Guedea-Edo F; Lino-Silva LS; Lozano-Borbalas A; Navarro-Martín A; Poitevin-Chacón A
    Arch Med Res; 2014 Apr; 45(3):229-36. PubMed ID: 24606815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-educated platelet miR-34c-3p and miR-18a-5p as potential liquid biopsy biomarkers for nasopharyngeal carcinoma diagnosis.
    Wang H; Wei X; Wu B; Su J; Tan W; Yang K
    Cancer Manag Res; 2019; 11():3351-3360. PubMed ID: 31114371
    [No Abstract]   [Full Text] [Related]  

  • 12. The Clinical Significance of IGF-1R and Relationship with Epstein-Barr Virus Markers: LMP1 and EBERs in Tunisian Patients with Nasopharyngeal Carcinoma.
    Baizig NM; Wided BA; Amine OE; Gritli S; ElMay M
    Ann Otol Rhinol Laryngol; 2020 Oct; 129(10):1011-1019. PubMed ID: 32468823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-18a promotes cancer progression through SMG1 suppression and mTOR pathway activation in nasopharyngeal carcinoma.
    Mai S; Xiao R; Shi L; Zhou X; Yang T; Zhang M; Weng N; Zhao X; Wang R; Liu J; Sun R; Qin H; Wang H
    Cell Death Dis; 2019 Oct; 10(11):819. PubMed ID: 31659158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a 7-microRNA signature in plasma as promising biomarker for nasopharyngeal carcinoma detection.
    Zhang H; Zou X; Wu L; Zhang S; Wang T; Liu P; Zhu W; Zhu J
    Cancer Med; 2020 Feb; 9(3):1230-1241. PubMed ID: 31856390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic comparison of plasma EBV DNA, anti-EBV antibodies and miRNA levels for early detection and prognosis of nasopharyngeal carcinoma.
    Tan LP; Tan GW; Sivanesan VM; Goh SL; Ng XJ; Lim CS; Kim WR; Mohidin TBBM; Mohd Dali NS; Ong SH; Wong CY; Sawali H; Yap YY; Hassan F; Pua KC; Koay CE; Ng CC; Khoo AS;
    Int J Cancer; 2020 Apr; 146(8):2336-2347. PubMed ID: 31469434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of MiR-155 in nasopharyngeal carcinoma is partly driven by LMP1 and LMP2A and downregulates a negative prognostic marker JMJD1A.
    Du ZM; Hu LF; Wang HY; Yan LX; Zeng YX; Shao JY; Ernberg I
    PLoS One; 2011 Apr; 6(4):e19137. PubMed ID: 21541331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic markers for early detection of nasopharyngeal carcinoma in a high risk population.
    Hutajulu SH; Indrasari SR; Indrawati LP; Harijadi A; Duin S; Haryana SM; Steenbergen RD; Greijer AE; Middeldorp JM
    Mol Cancer; 2011 May; 10():48. PubMed ID: 21535891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of matrix metalloproteinases by Epstein-Barr virus latent membrane protein 1 isolated from nasopharyngeal carcinoma.
    Lee DC; Chua DT; Wei WI; Sham JS; Lau AS
    Biomed Pharmacother; 2007 Oct; 61(9):520-6. PubMed ID: 17913445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent Advances in Assessing the Clinical Implications of Epstein-Barr Virus Infection and Their Application to the Diagnosis and Treatment of Nasopharyngeal Carcinoma.
    Yoshizaki T; Kondo S; Dochi H; Kobayashi E; Mizokami H; Komura S; Endo K
    Microorganisms; 2023 Dec; 12(1):. PubMed ID: 38276183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNAs in nasopharyngeal carcinoma.
    Spence T; Bruce J; Yip KW; Liu FF
    Chin Clin Oncol; 2016 Apr; 5(2):17. PubMed ID: 27121877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.